Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co.

140 Broadway,
New York, New York 10005
United States
(212) 483-1818
www.bbh.com

Brown Brothers Harriman & Co. is a private bank and investment firm focused on offering private investment services including investment counseling, private trusts, corporate lending, mutual funds, private and public equity, fixed income, mergers and acquisitions, and specialized investment services for a variety of public and private companies. Brown Brothers Harriman & Co. was founded in 1818 and based in New York, New York.


M&A Advisory Summary

Buyside vs Sellside

Year '19 '20 '21 '22 '23 '24 T
Buyside (0.2/yr) 5 1 - - - - 6
Sellside (0.0/yr) 2 - - - - - 2
  8

Most Recent

Target Company Date Value Type
Sign-up to View 2020-01-31 - Consumer Products
Sign-up to View 2013-12-04 263M USD Medical Products
Sign-up to View 2012-08-13 276M USD Medical Products
Sign-up to View 2012-03-12 2.2B USD Medical Products
Sign-up to View 2011-06-28 - Communications
Sign-up to View 2008-07-30 - Marketing
Sign-up to View 2006-09-14 1.0B USD Financial Services
Sign-up to View 2006-05-05 204M USD Communications
View All >>

Sector Experience

Sector # Value
Medical Products Sign-up to View
Communications Sign-up to View
Financial Services Sign-up to View
Consumer Products Sign-up to View
Marketing Sign-up to View
Total Sign-up to View

Geo Experience

State/Country # Value
United States Sign-up to View
  New York Sign-up to View
  Texas Sign-up to View
  Massachusetts Sign-up to View
Netherlands Antilles Sign-up to View
Domestic Sign-up to View
Cross-border Sign-up to View
Total Sign-up to View

Transaction Type Experience

Type # Value
Add-on Acquisition Sign-up to View
Merger Sign-up to View
Divestiture Sign-up to View
Total Sign-up to View

Top M&A Clients

Corporate (6) Deals
Sign-up to View
2
Sign-up to View
2
Sign-up to View
1

Deal Values

Value # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest ZOLL Medical Corporation
$2.2B (2012-03-12)